YARROW BIOSCIENCE ($YARW) posted quarterly earnings results for Q3 2026 on Thursday, November 12th. The company reported earnings of -$0.43 per share, beating estimates of -$0.72 by $0.29. The company also reported revenue of $0, equaling estimates of $0 by $0.
Stock price change since market open this morning: +7.72%
You can see Quiver Quantitative's $YARW stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
YARROW BIOSCIENCE Hedge Fund Activity
We have seen 11 institutional investors add shares of YARROW BIOSCIENCE stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SILVERARC CAPITAL MANAGEMENT, LLC added 301,919 shares (+inf%) to their portfolio in Q3 2026, for an estimated $6,799,215
- GEODE CAPITAL MANAGEMENT, LLC added 84,720 shares (+inf%) to their portfolio in Q3 2026, for an estimated $1,907,894
- MONASHEE INVESTMENT MANAGEMENT LLC added 40,000 shares (+inf%) to their portfolio in Q3 2026, for an estimated $900,800
- US BANCORP \DE\ added 4,992 shares (+inf%) to their portfolio in Q3 2026, for an estimated $112,419
- ASTER CAPITAL MANAGEMENT (DIFC) LTD added 3,179 shares (+inf%) to their portfolio in Q3 2026, for an estimated $71,591
- UBS GROUP AG added 1,744 shares (+inf%) to their portfolio in Q3 2026, for an estimated $39,274
- CITIGROUP INC added 232 shares (+inf%) to their portfolio in Q3 2026, for an estimated $5,224
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.